HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC/DoJ clearance procedures

This article was originally published in The Rose Sheet

Executive Summary

Any future agreement on merger clearance procedures would have to satisfy Senate Commerce Committee Chairman Fritz Hollings' (D-S.C.) concerns about concurrent jurisdiction, particularly for media mergers. FTC, DoJ notified Hollings, who also chairs Senate Appropriations/Commerce Subcommittee, May 20 that they would not follow through with March 5 agreement that divvied up jurisdiction by industry (1"The Rose Sheet" April 22, 2002, p. 8). Proposed compromise that would have given FTC jurisdiction over one-third of cable mergers was rejected by Commerce Committee staff May 17. DoJ cited "prospect of budgetary consequences" if it stood by original agreement; supplemental appropriations bills, marked up in Senate May 22, was potential vehicle for budget, salary cuts for agencies...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel